產(chǎn)品名稱 |
MDA-MB-330 |
商品貨號(hào) |
B165124 |
Organism |
Homo sapiens, human |
Tissue |
mammary gland; breast; Derived from metastatic site: pleural effusion |
Product Format |
frozen |
Morphology |
epithelial |
Culture Properties |
adherent |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
Infiltrating lobular carcinoma |
Age |
43 years |
Gender |
female |
Ethnicity |
Caucasian |
Applications |
The population exhibited a mixed phenotype when examined by immunofluorescence staining for tubulin, with some cells (type I) having extensive arrays and others (type II) a more diffuse reaction pattern. |
Karyotype |
modal number = 64 with one marker chromosome |
Images |
|
Clinical Data |
female Caucasian 43 years |
Antigen Expression |
Blood Type A; Rh+ |
Receptor Expression |
epidermal growth factor (EGF) |
Cellular Products |
tubulin; actin |
Tumorigenic |
No |
Effects |
No, in immunosuppressed mice Yes, in semisolid medium |
Comments |
The population exhibited a mixed phenotype when examined by immunofluorescence staining for tubulin, with some cells (type I) having extensive arrays and others (type II) a more diffuse reaction pattern. Most cells of the line stained positively for actin. This line grows very slowly (doubling time is 10 to 20 days) and never becomes confluent. |
Complete Growth Medium |
These cells are grown in Leibovitz's L-15 medium with 2 mM L-glutamine supplemented with:- 30 ng/ ml human recombinant EGF
- 0.016 mg/ml human recombinant insulin
- 2mM glutathione
- 20% fetal bovine serum
Do not filter EGF thru 0.22 micron filter. (Note: The L-15 medium formulation was devised for use in a free gas exchange with atmospheric air. A CO2 and air mixture is detrimental to cells when using this medium for cultivation)
|
Subculturing |
Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended Medium Renewal: Once per week Remove medium, add fresh 0.25% trypsin, 0.02% EDTA solution for 1 to 2 minutes, remove trypsin and let the culture sit at 37C until the cells detach. Add fresh medium, aspirate and dispense into new flasks. |
Cryopreservation |
Culture medium, 95%; DMSO, 5% |
Culture Conditions |
Temperature: 37.0°C Atmosphere: air, 100% |
STR Profile |
Amelogenin: X CSF1PO: 10 D13S317: 9 D16S539: 9,12 D5S818: 13 D7S820: 10,11 THO1: 8,9.3 TPOX: 8,11 vWA: 14,16 |
Isoenzymes |
AK-1, 1 ES-D, 1 G6PD, B GLO-I, 1 PGM1, 1 PGM3, 1 |
Population Doubling Time |
240 to 480 hrs |
Name of Depositor |
R Cailleau |
Deposited As |
Homo sapiens |
References |
Brinkley BR, et al. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res. 40: 3118-3129, 1980. PubMed: 7000337
Cruciger Q, et al. Morphological, biochemical and chromosomal characterization of breast tumor lines from pleural effusions. In Vitro 12: 331, 1976.
Siciliano MJ, et al. Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker. Cancer Res. 39: 919-922, 1979. PubMed: 427779
Cailleau R, et al. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14: 911-915, 1978. PubMed: 730202
|